» Articles » PMID: 34079367

Extreme Oncoplasty: Breast Conservation in Patients with Large, Multifocal, and Multicentric Breast Cancer

Overview
Publisher Dove Medical Press
Date 2021 Jun 3
PMID 34079367
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Extreme Oncoplastic Breast Conservation Surgery (EOBCS) is offered in selected patients with multifocal or multicentric breast cancer (MFMC). Recent evidence has suggested that EOBCS may be a valuable resource for patients with MFMC who may avoid the risk associated with mastectomy in favour of the benefits of breast conservation without risking their oncological outcomes. Our study examined the practice of EOBCS in two regional breast units in Glasgow, United Kingdom.

Materials And Methods: A prospectively collected database of 50 patients treated with EOBC in two breast units in Glasgow between 2007 and 2018 were evaluated, and clinical outcomes were observed.

Results: Fifty patients (median age 55) underwent EOBCS, of which 43 (86%) had invasive disease. Median tumour size was 55mm (50-90) and multifocal disease was identified in 22 (44%) patients. Nine patients (18%) were found to have positive margins and underwent a second procedure, with 6 (12%) proceeding to mastectomy. Five-year disease free survival rate was 91.5%, while cancer-specific survival was 95.7%.

Conclusion: EOBCS is oncologically safe in short-term follow-up. Large scale studies are required to confirm these preliminary results, in order to offer EOBCS as a valid option to patients with advanced or multifocal breast cancer.

Citing Articles

Comparative analysis of the degree of patient satisfaction after breast-conserving surgery with or without oncoplastic surgery: systematic review and meta-analysis.

Lisboa F, Giorgi L, Figueiredo A, Paulinelli R, de Sousa J Front Surg. 2024; 11:1396432.

PMID: 39086922 PMC: 11289670. DOI: 10.3389/fsurg.2024.1396432.


Breast Conservation Project: Clinical Outcomes of Extreme Oncoplastic Breast-Conserving Therapy Versus Mastectomy for Large and Multiple Lesions.

Jackson K, Millen J, Handy N, Orozco J, Stern S, Fancher C Ann Surg Oncol. 2024; 31(11):7582-7593.

PMID: 39048896 DOI: 10.1245/s10434-024-15799-4.


Oncoplastic surgery in the USA: a review of where we started, where we are today and where we are headed.

Willcox L, Losken A, Garcia Nores G Gland Surg. 2024; 13(5):749-759.

PMID: 38845836 PMC: 11150193. DOI: 10.21037/gs-23-363.


Evolution of breast conserving surgery-current implementation of oncoplastic techniques in breast conserving surgery: a literature review.

Torras I, Cebrecos I, Castillo H, Mension E Gland Surg. 2024; 13(3):412-425.

PMID: 38601289 PMC: 11002492. DOI: 10.21037/gs-23-454.


Oncoplastic breast surgery in Europe.

Daster K, Garcia R, Masannat Y, Kothari A Gland Surg. 2024; 13(2):248-256.

PMID: 38455355 PMC: 10915426. DOI: 10.21037/gs-23-380.


References
1.
Crown A, Laskin R, Rocha F, Grumley J . Extreme oncoplasty: Expanding indications for breast conservation. Am J Surg. 2019; 217(5):851-856. DOI: 10.1016/j.amjsurg.2019.01.004. View

2.
Munhoz A, Montag E, Gemperli R . Oncoplastic breast surgery: indications, techniques and perspectives. Gland Surg. 2014; 2(3):143-57. PMC: 4115743. DOI: 10.3978/j.issn.2227-684X.2013.08.02. View

3.
Giacalone P, Roger P, Dubon O, El Gareh N, Rihaoui S, Taourel P . Comparative study of the accuracy of breast resection in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol. 2006; 14(2):605-14. DOI: 10.1245/s10434-006-9098-5. View

4.
McIntosh J, ODonoghue J . Therapeutic mammaplasty--a systematic review of the evidence. Eur J Surg Oncol. 2011; 38(3):196-202. DOI: 10.1016/j.ejso.2011.12.004. View

5.
Silverstein M . Radical Mastectomy to Radical Conservation (Extreme Oncoplasty): A Revolutionary Change. J Am Coll Surg. 2016; 222(1):1-9. DOI: 10.1016/j.jamcollsurg.2015.10.007. View